Olanzapine and pregnancy [4]

Australian and New Zealand Journal of Psychiatry

Volumn 35, Issue 6, 2001, Pages 856-857

  Lim, L M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUPENTIXOL DECANOATE; OLANZAPINE; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; NEUROLEPTIC AGENT; PIRENZEPINE;

ADULT; CASE REPORT; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG INDICATION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GESTATIONAL AGE; HUMAN; LETTER; MALE; NEWBORN; PARANOID SCHIZOPHRENIA; PREGNANCY; PSYCHOSIS; RISK BENEFIT ANALYSIS; SIDE EFFECT; TREATMENT OUTCOME; DRUG EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; PIRENZEPINE; PREGNANCY;

EID: 0035543874     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2001.0971e.x     Document Type: Letter

References (5)

1. Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines
2. Antipsychotics during pregnancy
3. Olanzapine and pregnancy
4. Healthy outcome under olanzapine treatment in a pregnant woman
5. Antipsychotic use in pregnancy - What are the best treatment options?